English
Insider transactions
EDGARDIAMEDICA THERAPEUTICS INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 4 transactions, 450,650 shares
- Sum of shares × price per share: 3,443,324.846
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–19 of 19
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 Filed 2026-08-12 | Pauls Dietrich John Director · Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 60,200 | 0 | — | 128,791 | Direct (D) | No | F1, F2
| Open filing 0001760123-26-000004 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Semba Charles Pauling Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,412 | 0 | — | 40,412 | Direct (D) | No | F1
| Open filing 0001872863-26-000004 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Krop Julie Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 67,500 | 0 | — | 67,500 | Direct (D) | No | F1
| Open filing 0001643127-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Kellen Scott Officer: CFO Secretary | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 162,000 | 0 | — | 162,000 | Direct (D) | No | F1
| Open filing 0001490476-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Kuntz Richard Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,412 | 0 | — | 40,412 | Direct (D) | No | F1
| Open filing 0001341125-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Pauls Dietrich John Director · Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 380,000 | 0 | — | 380,000 | Direct (D) | No | F1
| Open filing 0001760123-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Lewis Tanya Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,412 | 0 | — | 40,412 | Direct (D) | No | F1
| Open filing 0001451038-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Parsons James T. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 51,189 | 0 | — | 51,189 | Direct (D) | No | F1
| Open filing 0001759855-26-000004 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | Giuffre Randall Michael Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,412 | 0 | — | 40,412 | Direct (D) | No | F1
| Open filing 0001759822-26-000004 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-03 | O'Connor Daniel J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,412 | 0 | — | 40,412 | Direct (D) | No | F1
| Open filing 0001376847-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Giuffre Randall Michael Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 6,175 | 8.42 | 51,993.5Derived: shares × price per share. Exact value 51993.50. | 398,587 | Direct (D) | No | F1
| Open filing 0001759822-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Semba Charles Pauling Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,355 | 8.42 | 28,249.1Derived: shares × price per share. Exact value 28249.10. | 47,963 | Direct (D) | No | F1
| Open filing 0001872863-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Parsons James T. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,095 | 8.42 | 84,999.9Derived: shares × price per share. Exact value 84999.90. | 97,949 | Direct (D) | No | F1
| Open filing 0001759855-26-000002 Read from the filing’s XML Dispute this row |
| 2025-11-25 Filed 2025-12-08 | STAHLBERG JAN 10% ownerTRILL AB 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 73,099 | 8.5749 | 626,816.6151Derived: shares × price per share. Exact value 626816.6151. | 8,825,742 | Indirect (I) See Footnote | No | F1
| Open filing 0001104659-25-119360 Read from the filing’s XML Dispute this row |
| 2025-11-24 Filed 2025-12-08 | STAHLBERG JAN 10% ownerTRILL AB 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 40,253 | 7.8931 | 317,720.9543Derived: shares × price per share. Exact value 317720.9543. | 8,752,643 | Indirect (I) See Footnote | No | F1
| Open filing 0001104659-25-119360 Read from the filing’s XML Dispute this row |
| 2025-11-21 Filed 2025-12-08 | STAHLBERG JAN 10% ownerTRILL AB 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 208,872 | 7.4092 | 1,547,574.4224Derived: shares × price per share. Exact value 1547574.4224. | 8,712,390 | Indirect (I) See Footnote | No | F1
| Open filing 0001104659-25-119360 Read from the filing’s XML Dispute this row |
| 2025-11-21 Filed 2025-11-25 | Parsons James T. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 12,000 | 2.20 | 26,400Derived: shares × price per share. Exact value 26400.00. | 87,854 | Direct (D) | No | F1
| Open filing 0001759855-25-000006 Read from the filing’s XML Dispute this row |
| 2025-11-21 Filed 2025-11-25 | Parsons James T. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 12,000 | 0 | — | 0 | Direct (D) | No | F1, F2
| Open filing 0001759855-25-000006 Read from the filing’s XML Dispute this row |
| 2025-11-20 Filed 2025-12-08 | STAHLBERG JAN 10% ownerTRILL AB 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 128,426 | 7.4067 | 951,212.8542Derived: shares × price per share. Exact value 951212.8542. | 8,503,518 | Indirect (I) See Footnote | No | F1
| Open filing 0001104659-25-119360 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Dialectic Life Sciences SPV LLC Voting common shares, no par value per share | 0 | 0.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-001133 Dispute this row |
| Dialectic LS Manager LLC Voting common shares, no par value per share | 0 | 0.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-001133 Dispute this row |
| Dialectic Capital Management, LP Voting common shares, no par value per share | 0 | 0.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-001133 Dispute this row |
| Dialectic Partners, LLC Voting common shares, no par value per share | 0 | 0.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-001133 Dispute this row |
| John Fichthorn Voting common shares, no par value per share | 0.3 | 153,983.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-001133 Dispute this row |
| Cooperman Leon G. Voting Common Shares, no par value | 6.6 | 3,450,000 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000945621-26-000352 Dispute this row |
| TRILL AB Common Shares, no par value | 16.9 | 8,825,742.00 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 4 | Open filing 0001104659-26-011569 Dispute this row |
| Jan Stahlberg Common Shares, no par value | 16.9 | 8,825,742.00 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 4 | Open filing 0001104659-26-011569 Dispute this row |
| Richard Jacinto II Voting Common Shares, no par value | 9.6 | 4,958,823 | 09/30/2025 Filed 2025-11-07 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-25-272616 Dispute this row |
| Cooperman Leon G. Voting Common Shares, no par value | 6.3 | 3,269,761 | 09/30/2025 Filed 2025-10-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000945621-25-000973 Dispute this row |
| Trill AB Common Shares, no par value | 15.02 | 7,764,465.00 | 08/14/2025 Filed 2025-09-04 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-25-087405 Dispute this row |
| Jan Stahlberg Common Shares, no par value | 15.02 | 7,764,465.00 | 08/14/2025 Filed 2025-09-04 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-25-087405 Dispute this row |
| Cooperman Leon G. Voting Common Shares, no par value | 6 | 3,110,220 | 07/23/2025 Filed 2025-08-27 | SCHEDULE 13G | Open filing 0000945621-25-000820 Dispute this row |
| Trill AB Common Shares, no par value | 13.14 | 6,764,465.00 | 07/23/2025 Filed 2025-07-30 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-072279 Dispute this row |
| Jan Stahlberg Common Shares, no par value | 13.14 | 6,764,465.00 | 07/23/2025 Filed 2025-07-30 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-072279 Dispute this row |
| TomEnterprise AB Common Shares, no par value | 16.28 | 8,383,577.00 | 07/23/2025 Filed 2025-07-30 | SCHEDULE 13G/AAmendment 4 | Open filing 0001104659-25-072272 Dispute this row |
| TomEnterprise Private AB Common Shares, no par value | 16.28 | 8,383,577.00 | 07/23/2025 Filed 2025-07-30 | SCHEDULE 13G/AAmendment 4 | Open filing 0001104659-25-072272 Dispute this row |
| Thomas von Koch Common Shares, no par value | 16.28 | 8,383,577.00 | 07/23/2025 Filed 2025-07-30 | SCHEDULE 13G/AAmendment 4 | Open filing 0001104659-25-072272 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,626,574 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 43,661 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.